{"created":"2023-05-15T16:33:38.018636+00:00","id":5941,"links":{},"metadata":{"_buckets":{"deposit":"82a2dae1-9c78-4b0f-8661-558f742f4d10"},"_deposit":{"created_by":2,"id":"5941","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"5941"},"status":"published"},"_oai":{"id":"oai:nagasaki-u.repo.nii.ac.jp:00005941","sets":["8:9"]},"author_link":["25798","25792","25797","25800","25791","25801","25793","25795","25794","25796","25799"],"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2014-11","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"5","bibliographicPageEnd":"472","bibliographicPageStart":"464","bibliographicVolumeNumber":"100","bibliographic_titles":[{"bibliographic_title":"International Journal of Hematology"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"VCAP (vincristine, cyclophosphamide, doxorubicin, and prednisone)-AMP (doxorubicin, ranimustine, and prednisone)-VECP (vindesine, etoposide, carboplatin, and prednisone) is a standard regimen for aggressive adult T cell leukemia-lymphoma (ATL). However, the efficacy of this regimen has not been fully elucidated for patients aged 70 years or older. Here, we retrospectively analyzed elderly patients with aggressive ATL at Nagasaki University Hospital between 1994 and 2010 to assess treatment outcomes. Of 148 evaluable patients, 54 were aged 70 years or older at diagnosis. The median survival time (MST) and overall survival (OS) at 2 years in elderly patients were 10.6 months and 22.1 %, respectively. Thirty-four patients received VCAP-AMP-VECP as the initial treatment, although the doses were reduced for most patients. In these patients, MST and OS at 2 years were 13.4 months and 26.6 %, respectively. Eleven of 34 patients (32 %) received maintenance oral chemotherapy after two or three cycles of VCAP-AMP-VECP, and MST and OS at 2 years were 16.7 months and 32.7 %, respectively. Our results suggest that the VCAP-AMP-VECP regimen may be effective and that maintenance oral chemotherapy may be considered as a therapeutic option for elderly patients with aggressive ATL.","subitem_description_type":"Abstract"}]},"item_2_description_63":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"International Journal of Hematology, 100(5), pp.464-472; 2014","subitem_description_type":"Other"}]},"item_2_publisher_33":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本血液学会"}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s12185-014-1665-0","subitem_relation_type_select":"DOI"}}]},"item_2_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"c The Japanese Society of Hematology 2014"},{"subitem_rights":"The original publication is available at www.springerlink.com"}]},"item_2_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"09255710","subitem_source_identifier_type":"ISSN"}]},"item_2_source_id_8":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"18653774","subitem_source_identifier_type":"ISSN"}]},"item_2_text_62":{"attribute_name":"出版者別言語","attribute_value_mlt":[{"subitem_text_value":"Japanese Society of Hematology"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Makiyama, Junya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Imaizumi, Yoshitaka"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Tsushima, Hideki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Taniguchi, Hiroaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Moriwaki, Yuji"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sawayama, Yasushi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Imanishi, Daisuke"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Taguchi, Jun"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Hata, Tomoko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Tsukasaki, Kunihiro"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Miyazaki, Yasushi"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-12-21"}],"displaytype":"detail","filename":"IJH100_464.pdf","filesize":[{"value":"308.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"IJH100_464.pdf","url":"https://nagasaki-u.repo.nii.ac.jp/record/5941/files/IJH100_464.pdf"},"version_id":"bfcbb505-1a7d-418c-a882-eecc68f88a7f"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Adult T cell leukemia-lymphoma (ATL)","subitem_subject_scheme":"Other"},{"subitem_subject":"Chemotherapy","subitem_subject_scheme":"Other"},{"subitem_subject":"Elderly patients","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience"}]},"item_type_id":"2","owner":"2","path":["9"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-01-26"},"publish_date":"2015-01-26","publish_status":"0","recid":"5941","relation_version_is_last":true,"title":["Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-05-16T02:55:50.102032+00:00"}